Table 3

Multivariate analysis

FactorsHR95% CIP value
Surgical method
 OpenRef
 Laparoscopic1.090.83 to 1.440.538
 Robotic1.000.82 to 1.210.970
Facility type
 Community cancer programRef
 Comprehensive community cancer program1.000.57 to 1.750.996
 Academic/research program0.970.55 to 1.700.906
 Integrated network cancer program0.810.45 to 1.460.485
Region
 NortheastRef
 Midwest1.210.95 to 1.530.118
 South0.860.67 to 1.100.234
 West1.070.79 to 1.450.676
Race
 WhiteRef
 Black1.591.25 to 2.020.000
 Hispanic0.860.55 to 1.320.481
 Asian/Pacific Islander1.150.65 to 2.020.629
 Other/unknown1.000.47 to 2.110.991
Insurance or not
 NoRef
 Yes0.990.60 to 1.630.966
 Unknown0.800.26 to 2.430.694
No high school degree 2008–2012, %
 ≥13%Ref
 <13%1.100.90 to 1.330.352
Charlson–-Deyo Comorbidity Index Score
 0Ref
 ≥11.451.21 to 1.750.000
Surgical field
 Simple hysterectomyRef
 Radical hysterectomy0.920.70 to 1.220.567
Histology
 Endometrioid carcinomaRef
 Serous carcinoma0.890.66 to 1.200.442
 Clear cell carcinoma0.710.43 to 1.170.180
 Carcinosarcoma1.701.29 to 2.240.000
Grade
 Well differentiatedRef
 Moderately differentiated1.501.03 to 2.200.037
 Poorly differentiated3.122.13 to 4.570.000
 Unknown1.581.02 to 2.450.041
Tumor size (cm)
 <2Ref
 ≥2 and <40.940.63 to 1.390.754
 ≥41.170.80 to 1.690.418
 Unknown1.230.81 to 1.870.326
 Lymphovascular invasion
 NoRef
 Yes1.711.42 to 2.060.000
 Unknown0.880.60 to 1.300.528
Surgical margin
 NegativeRef
 Positive1.270.78 to 2.070.343
 Unknown1.110.77 to 1.600.566
Adjuvant therapy
 NoRef
 Chemotherapy only0.790.58 to 1.080.135
 Radiation therapy only0.690.54 to 0.870.002
 Radiation therapy and chemotherapy0.630.48 to 0.820.001
 Unknown0.870.57 to 1.340.539